Featured Research

from universities, journals, and other organizations

Could A Popular HIV Drug Benefit Hepatitis B Patients?

Date:
May 4, 2006
Source:
Saint Louis University
Summary:
Saint Louis University School of Medicine researchers are studying the effectiveness of a drug for patients with chronic hepatitis B that is currently used to treat HIV.

Saint Louis University School of Medicine researchers are studying the effectiveness of a drug for patients with chronic hepatitis B that is currently used to treat HIV.

Hepatitis B patients currently take an antiviral called Hepsera, says Adrian Di Bisceglie, M.D., chief of hepatology at Saint Louis University School of Medicine. The drug under investigation in the study, called Tenofovir, is similar to Hepsera in that it is a “nucleotide analog” that helps stop the virus from propagating. Researchers will study Tenofovir’s efficacy compared to Hepsera’s in up to 300 patients worldwide.

“We have high hopes that Tenofovir will be more potent than the current drug regimen for hepatitis B patients,” Di Bisceglie says.

Hepatitis B is a disease passed down from mother to infant during pregnancy and has reached epidemic levels in China, Vietnam and sub-Saharan Africa.

“It is a terrible disease because it kills people in their prime of their lives – in their 30s, 40s and 50s,” Di Bisceglie says. “What makes it even more devastating is that there are mild non-specific symptoms or sometimes no symptoms at all.”

Most American women who undergo prenatal screening are also screened for hepatitis B, Di Bisceglie says, and because there is a safe, effective vaccine, hepatitis B is a “controllable” disease.

“But we hope this new antiviral can help improve the lives of patients with hepatitis B,” he says.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first M.D. degree west of the Mississippi River. Saint Louis University School of Medicine is a pioneer in geriatric medicine, organ transplantation, chronic disease prevention, cardiovascular disease, neurosciences and vaccine research, among others. The School of Medicine trains physicians and biomedical scientists, conducts medical research, and provides health services on a local, national and international level.


Story Source:

The above story is based on materials provided by Saint Louis University. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University. "Could A Popular HIV Drug Benefit Hepatitis B Patients?." ScienceDaily. ScienceDaily, 4 May 2006. <www.sciencedaily.com/releases/2006/05/060504075005.htm>.
Saint Louis University. (2006, May 4). Could A Popular HIV Drug Benefit Hepatitis B Patients?. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2006/05/060504075005.htm
Saint Louis University. "Could A Popular HIV Drug Benefit Hepatitis B Patients?." ScienceDaily. www.sciencedaily.com/releases/2006/05/060504075005.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins